0000899243-21-019978.txt : 20210519 0000899243-21-019978.hdr.sgml : 20210519 20210519181956 ACCESSION NUMBER: 0000899243-21-019978 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201118 FILED AS OF DATE: 20210519 DATE AS OF CHANGE: 20210519 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Consonance Life Sciences CENTRAL INDEX KEY: 0001824774 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39635 FILM NUMBER: 21941663 BUSINESS ADDRESS: STREET 1: 11 WESTCOTT ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 650-477-8183 MAIL ADDRESS: STREET 1: 11 WESTCOTT ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Consonance-HFW Acquisition Corp. CENTRAL INDEX KEY: 0001824893 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 981556622 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 PALMER SQUARE STREET 2: SUITE 305 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: (609) 921-2333 MAIL ADDRESS: STREET 1: 1 PALMER SQUARE STREET 2: SUITE 305 CITY: PRINCETON STATE: NJ ZIP: 08540 3/A 1 doc3a.xml FORM 3/A SUBMISSION X0206 3/A 2020-11-18 2020-11-18 0 0001824893 Consonance-HFW Acquisition Corp. CHFW 0001824774 Consonance Life Sciences C/O CONSONANCE-HFW ACQUISITION CORP. 1 PALMER SQUARE, SUITE 305 PRINCETON NJ 08540 1 0 0 0 Class B Ordinary Shares 2210000 D The shares will automatically convert into Class A Ordinary Shares at the time of the Issuer's initial business combination. This number includes up to 300,000 shares that are subject to forfeiture in the event the underwriters of the initial public offering of the Issuer's securities do not exercise in full their over-allotment as described in the Issuer's registration statement. These shares are directly held by Consonance Life Sciences, LLC ("Consonance Life Sciences"). This entity is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston may be deemed to have voting and investment discretion with respect to these shares and may be deemed to have shared beneficial ownership of these shares. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly. This Form 3 amendment is being filed to correct the original Form 3 filed on November 18, 2020. The original Form 3 incorrectly listed the amount of the securities as 2,300,000 Class B Ordinary Shares held by Consonance Life Sciences and incorrectly reported such shares in Table II. Consonance Life Sciences, LLC ("Consonance Life Sciences") is governed by a board of managers consisting of Mitchell Blutt, Benny Soffer and Kevin Livingston. Dr. Blutt is the Chairman of the Board of Directors (the "Board") of Consonance-HFW Acquisition Corp. (the "Issuer"). By virtue of its representation on the Issuer's Board, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, Consonance Life Sciences is deemed a director by deputization of the Issuer. /s/ Kevin Livingston, Manager of Consonance Life Sciences, LLC 2021-05-19